Oral vs vaginal progesterone
Oral is sedating and hepatic; vaginal targets endometrium with less systemic effect.
Head to head
Vaginal preferred for sleep-disruption or side-effect intolerance to oral.
Bottom line
Individualized care wins. We match the option to your history, risk profile, and goals.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.